Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo

1937.805 - 1962.083 Dr. Andrea Apolo

So I think that this is a really important study, and more studies are going to be done that are actually randomized. So this kind of set the stage, and we have retrospective data also. So I think this kind of sets the stage for the importance of ctDNA within this perioperative study, and then what to do if you do have a positive ctDNA response. how to follow the patients, kind of what to expect.